Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
BD strips remaining stake in Vyaire Medical for $435 million
March 19, 2018 Off

BD strips remaining stake in Vyaire Medical for $435 million

By Dino Mustafić

BD said Monday today it will divest its remaining, minority stake in Vyaire Medical to funds managed by Apax Partners for $435…

Cidara Therapeutics might have once-weekly treatment option for patients with difficult-to-treat and deadly invasive Candida infections
March 19, 2018 Off

Cidara Therapeutics might have once-weekly treatment option for patients with difficult-to-treat and deadly invasive Candida infections

By Dino Mustafić

The results reported by Cidara Therapeutics, for its lead antifungal candidate rezafungin acetate, which met all of its primary objectives,…

Boehringer Ingelheims’ snintedanib for treatment of a type of systemic sclerosis gets fast tracked by the FDA
March 19, 2018 Off

Boehringer Ingelheims’ snintedanib for treatment of a type of systemic sclerosis gets fast tracked by the FDA

By Dino Mustafić

Boehringer Ingelheim’s  nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease (SSc-ILD), has been put to the fast…

Baxter broadens its surgical hemostat and sealand portfolio with Recothrom and Preveleak acquisition
March 19, 2018 Off

Baxter broadens its surgical hemostat and sealand portfolio with Recothrom and Preveleak acquisition

By Dino Mustafić

Baxter International has completed the acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is…

Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer
March 19, 2018 Off

Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer

By Dino Mustafić

Matinas BioPharma has appointed Jerome D. Jabbour, Co-founder and President of Matinas, as its Chief Executive Officer (“CEO”) and a…

H7N9 influenza vaccine clinical trials begin
March 16, 2018 Off

H7N9 influenza vaccine clinical trials begin

By Dino Mustafić

Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling…

J&J gets offer from Platinum Equity to buy LifeScan for $2.1 billion
March 16, 2018 Off

J&J gets offer from Platinum Equity to buy LifeScan for $2.1 billion

By Dino Mustafić

Johnson & Johnson has received a binding offer from Platinum Equity, a private investment firm, to acquire its LifeScan business…

Amryt plans for series of agreements after an exclusive in-licence deal for a novel gene therapy platform, potentially exciting treatment for Epidermolysis bullosa
March 15, 2018 Off

Amryt plans for series of agreements after an exclusive in-licence deal for a novel gene therapy platform, potentially exciting treatment for Epidermolysis bullosa

By Dino Mustafić

Joe Wiley, CEO of Amryt, said Amryt has an ambitious plans for the remainder of 2018 as it looks forward to…

Midatech names new CEO to take over in June
March 15, 2018 Off

Midatech names new CEO to take over in June

By Dino Mustafić

Midatech said its CEO, Dr Jim Phillips will step down at the end of May 2018 after five years, and he…

FDA fast tracks Destiny Pharma’s candidate for prevention of infections like MRSA
March 15, 2018 Off

FDA fast tracks Destiny Pharma’s candidate for prevention of infections like MRSA

By Dino Mustafić

FDA has fast tracked Destiny Pharma’s lead clinical candidate exeporfinium chloride (XF-73) for the prevention of post-surgical staphylococcal infections such…

Posts pagination

Previous 1 … 3,396 3,397 3,398 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine